Diagnostic Information Generation and Use

• US 20110020785A1
• Filed: 07/28/2008
• Published: 01/27/2011
• Est. Priority Date: 07/26/2007
• Status: Abandoned Application

• Current Assignee: T2 Biosystems, Inc
• Original Assignee: T2 Biosystems, Inc
• Inventors: Lowery, Thomas J. JR., Elstrom, Tuan A., Koziarz, James J., Levinson, Douglas A.
• Application Number:
  US12/670,615
• Publication Number:
  US 20110020785A1
• Time in Patent Office: Days
• US Class Current: 435/5
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G16H 20/40 relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 50/80 for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
• CPC Class Codes: G16Z 99/00 Subject matter not provided for in other main groups of this subclass
• CPC Class Codes: Y02A 90/10 Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

This invention relates generally to a process for producing machine readable contextual diagnostic information and use of contextual diagnostic information for generating tangible and useful results. The process provides the highest level of integration of diagnostic information collected in a distributed or centralized system comprising diagnostic devices and a global computer network. More particularly, in certain embodiments, contextual diagnostic information are used in specific diagnostic related applications and business models including ecommerce.

Claims

1-77. -77. (canceled)

78. A medical diagnostic system comprising:

a diagnostic device configured to provide near real time analytical results; and

a processor member, responsive to the diagnostic device, configured to add augmentation parameters to the analytical results to form contextual diagnostic information,

wherein user access to the contextual diagnostic information is provided through a fee for information transaction.

79. The medical diagnostic system of claim 78, wherein the diagnostic device comprises a device configured to detect at least one of an analyte and a biomarker, the device having a support defining a well for holding a liquid sample comprising magnetic particles and the analyte or biomarker, the magnetic particles having binding moieties linked thereto, and an RF coil configured to detect a magnetic resonance response produced by exposing the liquid sample to a bias magnetic field created using one or more magnets and an RF excitation.

80. The medical diagnostic system of claim 79, wherein the diagnostic device is at least one of portable and part of a distributed processing network.

81. The medical diagnostic system of claim 79, wherein the augmentation parameters include any one or combination of:

position of the diagnostic device, location of the diagnostic device, velocity of the diagnostic device and frame of reference data.

82. The medical diagnostic system of claim 79, wherein the transaction comprises at least one of a database subscription and a fee for use at point of care communication.

83. The medical diagnostic system of claim 79, wherein the analyte is selected from the group consisting of a protein, a nucleic acid, a cell, a carbohydrate, a therapeutic agent, a polymer, and a virus.

84. The medical diagnostic system of claim 79, wherein the diagnostic device is in a testing location and the fee for information transaction is in an access location.

85. The medical diagnostic system of claim 84, wherein the diagnostic device is implanted, portable and/or part of a distributed processing network.

86. The medical diagnostic system of claim 84, wherein the testing location is different from the access location.

87. The medical diagnostic system of claim 84, wherein the testing location is a stationary point of care setting, a field location, or within an ambulatory/motional vehicle.

88. The medical diagnostic system of claim 84, wherein the testing location is a drive-through diagnostic center, and the diagnostic medical device is configured to allow testing with the diagnostic medical device of a person within a vehicle.

89. A medical diagnostic method comprising:

providing near real time analytical results using a diagnostic device;

adding augmentation parameters to the analytical results to form contextual diagnostic information using a processor member responsive to the diagnostic device; and

providing user access to the contextual diagnostic information through a fee for information transaction.

90. The medical diagnostic method of claim 89, wherein the providing near real time analytical results comprises using a device configured to detect at least one of an analyte and a biomarker, the device having a support defining a well for holding a liquid sample comprising magnetic particles and the analyte or biomarker, the magnetic particles having binding moieties linked thereto, and an RF coil configured to detect a magnetic resonance response produced by exposing the liquid sample to a bias magnetic field created using one or more magnets and an RF excitation.

91. The medical diagnostic method of claim 90, wherein the using a device comprises using at least one of portable device and part of a distributed processing network.

92. The medical diagnostic method of claim 90, further comprising using augmentation parameters including any one or combination of:

position of the diagnostic device, location of the diagnostic device, velocity of the diagnostic device and frame of reference data.

93. The medical diagnostic method of claim 90, wherein the transaction comprises at least one of a database subscription and a fee for use at point of care communication.

94. The medical diagnostic method of claim 90, wherein the analyte is selected from the group consisting of a protein, a nucleic acid, a cell, a carbohydrate, a therapeutic agent, a polymer, and a virus.

95. The medical diagnostic method of claim 90, wherein the diagnostic device is implanted, portable and/or part of a distributed processing network.

96. The medical diagnostic method of claim 95, further comprising using the diagnostic device in a testing location and performing the fee for information transaction in an access location.

97. The medical diagnostic method of claim 95, wherein the testing location is different from the access location.

98. The medical diagnostic method of claim 95, wherein the testing location is a stationary point of care setting, a field location, or within an ambulatory/motional vehicle.

99. The medical diagnostic method of claim 95, wherein the testing location is a drive-through diagnostic center, and the diagnostic medical device is configured to allow testing with the diagnostic medical device of a person within a vehicle.